drug · protein
elamipretide hydrochloride
Marketedupdated 5mo agoby Stealth BioTherapeutics Inc🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 20, 2027
112 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Feb 28, 2034method-of-use (U-4277)US 11083771
- Feb 28, 2034method-of-use (U-4277)US 11083772
- Feb 28, 2034method-of-use (U-4277)US 11771734
- Feb 28, 2034method-of-use (U-4277)US 12268724
- Feb 28, 2034method-of-use (U-4277)US 9687519
- Jan 20, 2027compositionUS 7576061112d
FDA exclusivities (1)
- Sep 19, 2030NCENew Chemical Entity (5y)4.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that